Carolinas Wealth Consulting’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Carolinas Wealth Consulting's EW Position: Q2 2025 in Review
Carolinas Wealth Consulting sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 36 shares — an estimated $2.61K sold.
Carolinas Wealth Consulting first reported a position in EW in Q2 2020 and held it in 20 quarters. The position peaked at $84.1K in Q2 2024. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Carolinas Wealth Consulting reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Carolinas Wealth Consulting sold 36 Edwards Lifesciences shares in Q2 2025, an estimated $2.61K.
- Carolinas Wealth Consulting first reported a position in Edwards Lifesciences in Q2 2020 and held it in 20 quarters.
- Carolinas Wealth Consulting's Edwards Lifesciences position peaked at $84.1K in Q2 2024.
- 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.